RAMM Pharma Corp. Announces Appointment of new Interim-Chief Financial Officer
December 09, 2022 16:30 ET
|
RAMM Pharma Corp.
TORONTO, Dec. 09, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to announce the appointment of José Roldan as...
RAMM Pharma Corp. Acquires Leading European Hemp Manufacturer HemPoland
September 06, 2022 09:54 ET
|
RAMM Pharma Corp.
TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to announce that today it has acquired all of...
RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid
August 17, 2022 07:32 ET
|
RAMM Pharma Corp.
TORONTO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces its intention to commence a normal course...
Ramm Pharma Announces Cease Trade Order
February 28, 2022 18:51 ET
|
RAMM Pharma Corp.
TORONTO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Ramm Pharma Corp. (CSE: RAMM) (the “Company”). On February 22, 2022, the Company announced that, for reasons set out in its news release of February 22,...
Ramm Pharma Announces Application for Management Cease Trade Order
February 22, 2022 17:30 ET
|
RAMM Pharma Corp.
TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Ramm Pharma Corp. (CSE: RAMM) (the “Company”) announces today that it has made an application to relevant Canadian securities regulators to approve a...
RAMM Provides Update on European Operations
February 22, 2022 08:40 ET
|
RAMM Pharma Corp.
TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...
New CBD Regulatory Framework Published by France’s Ministry of Health Opens New Commercial Opportunities for RAMM Pharma’s European Operations
January 05, 2022 07:30 ET
|
RAMM Pharma Corp.
TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp., including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...
RAMM Pharma Corp. Welcomes Proposed Legalization of Recreational Cannabis in Germany
December 01, 2021 09:03 ET
|
RAMM Pharma Corp.
TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...
RAMM Pharma Announces Resignation of Director
September 15, 2021 16:30 ET
|
RAMM Pharma Corp.
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and...
RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid
July 06, 2021 07:30 ET
|
RAMM Pharma Corp.
TORONTO, July 06, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces its intention to commence a normal course...